OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Organization: Brigham and Women's Hospital

11 Projects | 7 Researchers | $1,677,282 Invested

2016

Brigham and Women's Hospital

Dennis Selkoe, MD

Neurally-derived exosomes for the diagnosis and staging of sporadic Alzheimer's disease

  • Funding Amount: $307,782
  • Organization Type: Academic/Nonprofit
  • Program: Biomarkers
  • Target: zzAbeta
  • Status: Closed

2016

Brigham and Women's Hospital

Elizabeth Bradshaw, PhD

Identification of small molecules that modulate microglia/macrophage uptake in primary human cells

  • Funding Amount: $150,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Systemic Inflammation
  • Status: Closed

2013

Brigham and Women's Hospital

Nathalie Pochet, PhD

Integrative genomic approach to prioritize targets for drug discovery and development in Alzheimer's disease and aging-related cognitive decline

  • Funding Amount: $135,000
  • Organization Type: Academic/Nonprofit
  • Program: Prevention
  • Status: Closed

2013

Brigham and Women's Hospital

Peter Lansbury, PhD

Characterizing the mitophenotypes of Alzheimer's disease: peripheral cell biomarkers for patient selection and measurement of drug response.

  • Funding Amount: $100,000
  • Organization Type: Academic/Nonprofit
  • Program: Biomarkers
  • Status: Closed

2012

Brigham and Women's Hospital

Marcie Glicksman, PhD

Collaborative CNS Screening Initiaitve

  • Funding Amount: $123,433
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed

2010

Brigham and Women's Hospital

Michael Wolfe, PhD

Targeting the Tau Message for Dementia

  • Funding Amount: $125,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed

2008

Brigham and Women's Hospital

Michael Wolfe, PhD

Selective Amyloid-Lowering Agents: Year 2

  • Funding Amount: $130,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed

2006

Brigham and Women's Hospital

Michael Wolfe, PhD

Selective Amyloid-Lowering Agents

  • Funding Amount: $130,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed

2004

Brigham and Women's Hospital

Kenneth Kosik, MD

The Development of CDK5 Inhibitors

  • Funding Amount: $199,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed

2001

Brigham and Women's Hospital

Kenneth Kosik, MD

Identifying Drugs That Inhibit Kinase-Induced Dissociation of Tau From Microtububles

  • Funding Amount: $130,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed
View More